SS

Shikha Sharma

Active Director Director DIN 11108085
DIN 11108085 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shikha Sharma

Data last updated:

Shikha Sharma is a Director at Nextray Remedies India Private Limited (since 2025) and Director at Nextray Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma.

DIN 11108085
Primary Designation Director
Industry Pharma
First Appointment 15 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Dec 20252025Active
Director15 May 20252025Active

Directorship timeline

Open interactive timeline →
Nextray Remedies India Private Limited
Nextray Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shikha Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shikha Sharma

Shikha Sharma currently holds 2 directorships: Nextray Remedies India Private Limited (Director, since 20 Dec 2025); Nextray Pharmaceuticals Private Limited (Director, since 15 May 2025).

Shikha Sharma was first appointed on 15 May 2025 as Director at Nextray Pharmaceuticals Private Limited.

The current boards of Shikha Sharma's companies include Babita (Nextray Remedies India Private Limited), Himani (Nextray Remedies India Private Limited), Shadab (Nextray Remedies India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available